Arrowhead Pharmaceuticals · 12 hours ago
Summer Intern, Discovery Pharmacology (CNS)
Arrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative drugs that treat intractable diseases through RNA interference. The Discovery Pharmacology Intern will support research efforts by characterizing protein expression in human cell lines and analyzing experimental data, ultimately summarizing findings in a scientific poster at the end of the internship.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Support experiments to characterize ATXN1 protein expression in human cell lines, including healthy and patient-derived models
Perform cell culture and aseptic techniques under supervision
Conduct immunoassays, including use of platforms such as JESS, as applicable
Analyze experimental data and organize results using appropriate tools
Maintain detailed and accurate experimental records in accordance with laboratory standards
Summarize research findings and prepare a scientific poster and/or PowerPoint presentation
Present project results to the research team toward the end of the internship
Collaborate with team members and participate in group discussions and meetings
Qualification
Required
Currently enrolled student at an accredited university or college, majoring in a biology-related field such as Cell Biology, Molecular Biology, Human Biology, Neuroscience, or a related discipline
Completion of relevant coursework in biology or life sciences
Completion of coursework in Molecular Biology, Cell Biology, Neurobiology, and/or Biotechnology
Familiarity with protein expression analysis, immunoassays, or cell-based assays
Interest in translational research or neuroscience-related drug discovery
Proficiency in Microsoft Office applications
Strong curiosity and motivation to learn new laboratory techniques
All applicants must have authorization to work in the US for a company
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
2026-01-08
Company data provided by crunchbase